Joint projects

Projects granted by the Ministry of Economy and Competitiveness of the Government of Spain, in which Reig Jofre participates:

  • Project ACINETOCLINIC

    Project title: TRANSITION TO CLINICAL INVESTIGATION PHASE FOR LICENSE OF THE FIRST VACCINE AGAINST DRUG RESISTANT ACINETOBACTER BAUMANNII (ACINETOCLINIC)
    Reference number: RTC-2016- 5161-1
    Partners: Vaxdyn
    Laboratorio Reig Jofre SA
    Draconis Pharma
    Instituto de Biomedicina de Sevilla (IBIS)
    Hospital Universitario Virgen del Rocío (HUVR)
    Centro Tecnológico Leitat
    Funding Agency: Ministry of Economy and Competitiveness, co-financed through EU-FEDER funds, within the State Program 2016 Challenges & Colaboration of the State Research Agency, with the main objective of Promoting technological development, innovation and quality research.
    Objective: Complete the transition to clinical development in humans (Phase I in healthy volunteers) of the first universal vaccine against infections caused by bacteria resistant to Acinetobacter baumannii antibiotics (VxD-001 vaccine).
    Duration: 2016-2019

  • Project PredictGYN

    Project title: DEVELOPMENT OF NEW APPROACHES IN THE INDIVIDUALIZED MANAGEMENT OF GYNECOLOGICAL CANCER PATIENTS (PredictGYN)
    Reference number: RTC-2015-3821-1
    Partners: Ability Pharmaceuticals SL
    Althia Health SL
    Fundacio Hospital Universitari Vall d'Hebron - Institut de Recerca
    Institut de Recerca Biomedica de Lleida
    Fundacio Privada Dr. Pifarre
    Laboratorio Reig Jofre SA
    Oryzon Genomics Diagnostico SL
    Funding Agency: Ministry of Economy and Competitiveness, within the State Program of Research, Development and Innovation Oriented to the Challenges of Society under the State Plan of Scientific and Technical Research, and Innovation 2013-2016.
    Objective: Identification of molecular markers to develop a prognostic test for patients with endometrial and ovarian cancer. Development of new personalized therapy strategies in endometrial cancer.
    Duration: 2015-2018

  • Project NANOMUC

    Project title: DEVELOPMENT OF INNOVATIVE FORMULATIONS OF MUCOADHESIVE NANOPARTICLES FOR THE TREATMENT OF MUCOSAL ULCERS (NANOMUC)
    Reference number: RTC-2015-4437-1
    Partners: Bionanoplus SL
    Laboratorio Reig Jofre SA
    Universidad de Navarra
    Universidad de Sevilla
    Funding Agency: Ministry of Economy and Competitiveness, within the State Program of Research, Development and Innovation Oriented to the Challenges of Society under the State Plan of Scientific and Technical Research, and Innovation 2013-2016.
    Objective: Development of controlled drug release treatments using innovative formulations of mucoadhesive polymeric nanoparticles. This will allow a longer residence of active principles in the mucous, combining local and systemic action, and resulting in a more effective treatment.
    Duration: 2015-2017

  • Project CURE4B

    Project title: CURE4B
    Reference number: RTC-2015-4319-1
    Partners: Fundacio per a la recerca i la docencia Sant Joan de Deu (FSJD)
    Institut Catala d’Oncologia
    Laboratorio Reig Jofre SA
    Vcn Biosciences SL
    Funding Agency: Ministry of Economy and Competitiveness, within the State Program of Research, Development and Innovation Oriented to the Challenges of Society under the State Plan of Scientific and Technical Research, and Innovation 2013-2016.
    Objective: Development and validation of oncolytic virus VCN-01 as a clinical candidate for retinoblastoma treatment, the most common type of eye cancer in children.
    Duration:: 2015-2018

 

Projects in collaboration with scientific societies and research groups:

  • Project on Seawater : Delphin Study and STERIMAR Survey

    Project title: Social-health research program for physiological solutions of seawater
    Partners: Spanish Society of Outpatient Pediatrics and Primary Care (SEPEAP)
    Spanish Society of Allergology and Clinical Immunology (SEAIC)
    Spanish Society of Otorhinolaryngology (SEORL)
    Laboratorio Reig Jofre SA
    Methodology & Objectives:
    Study on the specialists’ opinion in the use of seawater (presentation and decalogue available only in Spanish):
    • Study with Delphi methodology among 175 specialists in the treatment of upper respiratory tract diseases (50% Paediatrics, 30% Otorhinolaryngology, 20% Allergology).
    • To achieve the highest possible degree of consensus on the effects, use as adjuvant treatment, and clinical experience with nasal washes with seawater.

    Survey of seawater users (presentation available only in Spanish):
    • Survey with CATI methodology of 1,350 seawater users as adjuvant treatment of upper respiratory tract diseases (89% congestion, 80% mucus, 70% rhinorrhea).
    • To obtain objective data on the follow-up degree of the medical recommendation on nasal washes with seawater, habits of use, and perception of benefits and overall satisfaction.
    Duration: 2016-2017

This site uses only technical third party cookies to provide better service, when browsing this website you agree to its use. See ourlegal advice. Agree

DMC Firewall is a Joomla Security extension!